Clinical features of malignant syndrome in Parkinson's disease and related neurological disorders
- 1 April 2003
- journal article
- case report
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 9, 15-23
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Circadian rhythms in the release of vasoactive intestinal polypeptide and arginine-vasopressin in organotypic slice culture of rat suprachiasmatic nucleusNeuroscience Letters, 1994
- Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual periodNeurology, 1993
- Evaluation of gastric emptying in Parkinson's diseaseJournal of the Autonomic Nervous System, 1993
- Possible Central Effect of Dantrolene Sodium in Neuroleptic Malignant SyndromeJournal of Clinical Psychopharmacology, 1986
- Neuroleptic malignant syndromeAmerican Journal of Psychiatry, 1985
- Fatal hyperpyrexia after withdrawal of levodopaNeurology, 1984
- Sympathoadrenomedullary hyperactivity in the neuroleptic malignant syndrome: a case reportAmerican Journal of Psychiatry, 1981
- Neuroleptic Malignant Syndrome-like State Following a Withdrawal of Antiparkinsonian DrugsJournal of Nervous & Mental Disease, 1981
- Neuroleptic malignant syndromeNeurology, 1981
- Paralysis agitans of early onset with marked diurnal fluctuation of symptomsNeurology, 1973